The first results indicating that high-affinity SST antagonists that poorly internalize into tumor cells perform more effectively than corresponding agonists that are highly internalized into tumor cells were considered to be at the forefront of a paradigm shift in nuclear oncology imaging (Ginj et al., 2006b). Here, SST is linked to neoplasm.